Mechanisms for Ductus Arteriosus Closure

Seminars in Perinatology

Volumn 36, Issue 2, 2012, Pages 92-97

  Coceani, Flavio ^a   Baragatti, Barbara ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Ductus arteriosus; Fetal physiology; Neonatal physiology; Oxygen sensing

Indexed keywords

ANGIOTENSIN II; CYTOCHROME P450; ENDOTHELIN 1; NITRIC OXIDE; OXYGEN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VOLTAGE GATED POTASSIUM CHANNEL;

ARTERY CONSTRICTION; ARTERY INTIMA; BLOOD OXYGEN TENSION; BLOOD VESSEL WALL; DUCTUS ARTERIOSUS; HUMAN; HYPOXIA; NONHUMAN; OXYGEN SENSING; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SHEAR STRESS; THROMBOCYTE; VASODILATATION;

DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; KV1.5 POTASSIUM CHANNEL; POTASSIUM CHANNELS, VOLTAGE-GATED; PREGNANCY; REACTIVE OXYGEN SPECIES; VENTRICULAR REMODELING;

EID: 84858261542     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.09.018     Document Type: Review

References (69)

1. Smith G.C. The pharmacology of the ductus arteriosus. Pharmacol Rev 1998, 50:35-58.
2. Weir E.K., López-Barneo J., Buckler K.J., et al. Acute oxygen-sensing mechanisms. N Engl J Med 2005, 353:2042-2055.
3. Wu G.R., Jing S., Momma K., et al. The effect of vitamin A on contraction of the ductus arteriosus in fetal rat. Pediatr Res 2001, 49:747-754.
4. Baragatti B., Ciofini E., Scebba F., et al. Cytochrome P-450 3A13 and endothelin jointly mediate ductus arteriosus constriction to oxygen in mice. Am J Physiol Heart Circ Physiol 2011, 300:H892-H901.
5. Weir E.K., Archer S.L. The role of redox changes in oxygen sensing. Respir Physiol Neurobiol 2010, 174:182-191.
6. Coceani F., Breen C.A., Lees J.G., et al. Further evidence implicating a cytochrome P-450-mediated reaction in the contractile tension of the lamb ductus arteriosus. Circ Res 1988, 62:471-477.
7. Coceani F., Kelsey L., Seidlitz E., et al. Inhibition of the contraction of the ductus arteriosus to oxygen by 1-aminobenzotriazole, a mechanism-based inactivator of cytochrome P450. Br J Pharmacol 1996, 117:1586-1592.
8. Coceani F., Kelsey L., Ackerley C., et al. Cytochrome P450 during ontogenic development: Occurrence in the ductus arteriosus and other tissues. Can J Physiol Pharmacol 1994, 72:217-226.
9. 2 constriction?. Can J Physiol Pharmacol 1989, 67:1448-1450.
10. Coceani F., Armstrong C., Kelsey L. Endothelin is a potent constrictor of the lamb ductus arteriosus. Can J Physiol Pharmacol 1989, 67:902-904.
11. 2 constriction but not closure of ductus arteriosus. Am J Physiol Heart Circ Physiol 1999, 277:H1521-H1531.
12. Coceani F., Kelsey L., Seidlitz E. Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth. Can J Physiol Pharmacol 1992, 70:1061-1064.
13. Coceani F., Kelsey L. Endothelin-1 release from the lamb ductus arteriosus: Are carbon monoxide and nitric oxide regulatory agents?. Life Sci 2000, 66:2613-2623.
14. Costa M., Barogi S., Socci N.D., et al. Gene expression in ductus arteriosus and aorta: Comparison of birth and oxygen effects. Physiol Genomics 2006, 25:250-262.
15. Yokoyama U., Sato Y., Akaike T., et al. Maternal vitamin A alters gene profiles and structural maturation of the rat ductus arteriosus. Physiol Genomics 2007, 31:139-157.
16. Taniguchi T., Azuma H., Okada Y., et al. Endothelin-1-endothelin receptor type A mediates closure of rat ductus arteriosus at birth. J Physiol 2001, 537:579-585.
17. Shen J., Nakanishi T., Gu H., et al. The role of endothelin in oxygen-induced contraction of the ductus arteriosus in rabbit and rat fetuses. Heart Vessels 2002, 16:181-188.
18. Agren P., Cogolludo A.L., Kessels C.G., et al. Ontogeny of chicken ductus arteriosus response to oxygen and vasoconstrictors. Am J Physiol Regul Integr Comp Physiol 2007, 292:R485-R496.
19. Takizawa T., Horikoshi E., Shen M.H., et al. Effects of TAK-044, a nonselective endothelin receptor antagonist, on the spontaneous and indomethacin- or methylene blue-induced constriction of the ductus arteriosus in rats. J Vet Med Sci 2000, 62:505-509.
20. Baragatti B., Coceani F. Arachidonic acid epoxygenase and 12(S)-lipoxygenase: Evidence of their concerted involvement in ductus arteriosus constriction to oxygen. Can J Physiol Pharmacol 2011, 89:329-334.
21. v channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: Implications for infants with patent ductus arteriosus. Circulation 2004, 110:1372-1379.
22. Kajimoto H., Hashimoto K., Bonnet S.N., et al. Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: A newly recognized mechanism for sustaining ductal constriction. Circulation 2007, 115:1777-1788.
23. 2 constriction contributing to patent ductus arteriosus. Pediatr Res 2008, 63:176-181.
24. 2+ channels promote oxygenation-induced closure of the rat ductus arteriosus not only by vasoconstriction but also by neointima formation. J Biol Chem 2009, 284:24025-24034.
25. Fineman J.R., Takahashi Y., Roman C., et al. Endothelin-receptor blockade does not alter closure of the ductus arteriosus. Am J Physiol Heart Circ Physiol 1998, 275:H1620-H1626.
26. Michelakis E., Rebeyka I., Bateson J., et al. Voltage-gated potassium channels in human ductus arteriosus. Lancet 2000, 356:134-137.
27. Waleh N., Hodnick R., Jhaveri N., et al. Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency. Pediatr Res 2010, 68:292-297.
28. Chorne N., Jegatheesan P., Lin E., et al. Risk factors for persistent ductus arteriosus patency during indomethacin treatment. J Pediatr 2007, 151:629-634.
29. Clyman R.I., Mauray F., Roman C., et al. Effects of antenatal glucocorticoid administration on ductus arteriosus of preterm lambs. Am J Physiol Heart Circ Physiol 1981, 241:H415-H420.
30. Momma K., Nishihara S., Ota Y. Constriction of the fetal ductus arteriosus by glucocorticoid hormones. Pediatr Res 1981, 15:19-21.
31. Docherty C.C., Kalmar-Nagy J., Engelen M., et al. Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol 2001, 281:R261-R268.
32. Momma K., Nakanishi T., Imamura S. Inhibition of in vivo constriction of fetal ductus arteriosus by endothelin receptor blockade in rats. Pediatr Res 2003, 53:479-485.
33. Michaelson D., Silletti J., Murphy G., et al. Differential localization of Rho GTPases in live cells: Regulation by hypervariable regions and RhoGDI binding. J Cell Biol 2001, 152:111-126.
34. + current in rat intrapulmonary arterial myocytes by endothelin-1. Am J Physiol Lung Cell Mol Physiol 1998, 274:L842-L853.
35. Keck M., Resnik E., Linden B., et al. Oxygen increases ductus arteriosus smooth muscle cytosolic calcium via release of calcium from inositol triphosphate-sensitive stores. Am J Physiol Lung Cell Mol Physiol 2005, 288:L917-L923.
36. Jones S.A., Adamson S.L., Bishai I., et al. Eicosanoids in third ventricular cerebrospinal fluid of fetal and newborn sheep. Am J Physiol Regul Integr Comp Physiol 1993, 264:R135-R142.
37. Coceani F., Olley P.M. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol 1973, 51:220-225.
38. Clyman R.I., Mauray F., Roman C., et al. Factors determining the loss of ductus arteriosus responsiveness to prostaglandin E. Circulation 1983, 68:433-436.
39. 2, and the nitric oxide donor, 3-morpholinosydnonimine, in lambs and their clinical implications. Br Heart J 1995, 73:177-181.
40. 2 receptors in fetal and newborn lamb ductus arteriosus. Am J Physiol Heart Circ Physiol 2001, 280:H2342-H2349.
41. 2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus. Nat Med 2002, 8:91-92.
42. Chang H.Y., Locker J., Lu R., et al. Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice. Circulation 2010, 121:529-536.
43. Takizawa T., Oda T., Arishima K., et al. Inhibitory effect of enalapril on the constriction of the ductus arteriosus in newborn rats. J Vet Med Sci 1994, 56:605-606.
44. Baragatti B., Brizzi F., Barogi S., et al. Interactions between NO, CO and an endothelium-derived hyperpolarizing factor (EDHF) in maintaining patency of the ductus arteriosus in the mouse. Br J Pharmacol 2007, 151:54-62.
45. Treszl A., Szabo M., Dunai G., et al. Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates. Pediatr Res 2003, 54:753-755.
46. 2 sensor in rat arterioles and skeletal muscle cells. Am J Physiol Heart Circ Physiol 2001, 280:H1840-H1845.
47. Olley P.M., Coceani F., Bodach E. E-type prostaglandins: A new emergency therapy for certain cyanotic congenital heart malformations. Circulation 1976, 53:728-731.
48. Fay F.S., Cooke P.H. Guinea pig ductus arteriosus. II. Irreversible closure after birth. Am J Physiol 1972, 222:841-849.
49. Mason C.A., Bigras J.L., O'Blenes S.B., et al. Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med 1999, 5:176-182.
50. 4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest 2006, 116:3026-3034.
51. 2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A. J Biol Chem 2008, 283:28702-28709.
52. Clyman R.I., Tannenbaum J., Chen Y.Q., et al. Ductus arteriosus smooth muscle cell migration on collagen: Dependence on laminin and its receptors. J Cell Sci 1994, 107(Pt 4):1007-1018.
53. Jin M.H., Yokoyama U., Sato Y., et al. DNA microarray profiling identified a new role of growth hormone in vascular remodeling of rat ductus arteriosus. J Physiol Sci 2011, 61:167-179.
54. Clyman R.I., Goetzman B.W., Chen Y.Q., et al. Changes in endothelial cell and smooth muscle cell integrin expression during closure of the ductus arteriosus: An immunohistochemical comparison of the fetal, preterm newborn, and full-term newborn rhesus monkey ductus. Pediatr Res 1996, 40:198-208.
55. Katsumi A., Orr A.W., Tzima E., et al. Integrins in mechanotransduction. J Biol Chem 2004, 279:12001-12004.
56. Kelly D.J., Cox A.J., Gow R.M., et al. Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension 2004, 44:195-202.
57. Zou Y., Akazawa H., Qin Y., et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004, 6:499-506.
58. Fay F.S. Biochemical basis for response of ductus arteriosus to oxygen. Fetal and Neonatal Physiology 1973, 136-140. Cambridge University Press, NY. K.S. Comline, K.W. Cross, G.S. Dawes, P.W. Nathanielsz (Eds.).
59. Kajino H., Goldbarg S., Roman C., et al. Vasa vasorum hypoperfusion is responsible for medial hypoxia and anatomic remodeling in the newborn lamb ductus arteriosus. Pediatr Res 2002, 51:228-235.
60. Wolinsky H., Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res 1967, 20:409-421.
61. Tannenbaum J.E., Waleh N.S., Mauray F., et al. Transforming growth factor-beta protein and messenger RNA expression is increased in the closing ductus arteriosus. Pediatr Res 1996, 39:427-434.
62. Clyman R.I., Seidner S.R., Kajino H., et al. VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus. Am J Physiol Regul Integr Comp Physiol 2002, 282:R199-R206.
63. Echtler K., Stark K., Lorenz M., et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010, 16:75-82.
64. Fujioka K., Morioka I., Miwa A., et al. Does thrombocytopenia contribute to patent ductus arteriosus?. Nat Med 2011, 17:29-31.
65. Shah N.A., Hills N.K., Waleh N., et al. Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment. J Pediatr 2011, 158:919-923.
66. Bergwerff M., DeRuiter M.C., Gittenberger-de Groot A.C. Comparative anatomy and ontogeny of the ductus arteriosus, a vascular outsider. Anat Embryol (Berl) 1999, 200:559-571.
67. Hamrick S.E., Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010, 125:1020-1030.
68. Sodini D., Baragatti B., Barogi S., et al. Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse. Br J Pharmacol 2008, 153:1631-1640.
69. Baragatti B., Scebba F., Sodini D., et al. Dual, constrictor-to-dilator, response of the mouse ductus arteriosus to the microsomal prostaglandin E synthase-1 inhibitor, 2-(6-chloro-1H-phenanthro[9,10d]imidazole-2-yl)isophthalonitrile. Neonatology 2011, 100:139-146.